From: Exploring venlafaxine pharmacokinetic variability with a phenotyping approach, a multicentric french-swiss study (MARVEL study)
Expected prevalence of responders
Number of responders
Number of non responders
Total sample size
50%
82
164
33%
63
125
188
28%
59
146
205